Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
MMWR Morb Mortal Wkly Rep ; 73(18): 417-419, 2024 May 09.
Article in English | MEDLINE | ID: mdl-38722800

ABSTRACT

Malaria is a severe and potentially fatal mosquitoborne disease caused by infection with Plasmodium spp. parasites. Although malaria is no longer endemic in the United States, imported infections are reported annually; the primary risk group has been U.S. residents traveling to areas where malaria is endemic (1). In 2023, sporadic locally acquired mosquito-transmitted malaria cases were reported in several U.S. states (2,3). This report describes increases in imported malaria cases in 2023 compared with 2022 in three public health jurisdictions along the U.S. southern border.


Subject(s)
Communicable Diseases, Imported , Malaria , Humans , Malaria/epidemiology , Communicable Diseases, Imported/epidemiology , United States/epidemiology , Travel
2.
PLoS One ; 16(12): e0261230, 2021.
Article in English | MEDLINE | ID: mdl-34919584

ABSTRACT

The systematic screening of asymptomatic and pre-symptomatic individuals is a powerful tool for controlling community transmission of infectious disease on college campuses. Faced with a paucity of testing in the beginning of the COVID-19 pandemic, many universities developed molecular diagnostic laboratories focused on SARS-CoV-2 diagnostic testing on campus and in their broader communities. We established the UC Santa Cruz Molecular Diagnostic Lab in early April 2020 and began testing clinical samples just five weeks later. Using a clinically-validated laboratory developed test (LDT) that avoided supply chain constraints, an automated sample pooling and processing workflow, and a custom laboratory information management system (LIMS), we expanded testing from a handful of clinical samples per day to thousands per day with the testing capacity to screen our entire campus population twice per week. In this report we describe the technical, logistical, and regulatory processes that enabled our pop-up lab to scale testing and reporting capacity to thousands of tests per day.


Subject(s)
COVID-19 Nucleic Acid Testing/methods , COVID-19/diagnosis , Clinical Laboratory Techniques/methods , Diagnostic Tests, Routine/methods , Mass Screening/methods , Pandemics/prevention & control , Diagnostic Screening Programs , Humans , Universities
3.
Emerg Infect Dis ; 20(2): 248-56, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24447640

ABSTRACT

Fungal endophthalmitis is a rare but serious infection. In March 2012, several cases of probable and laboratory-confirmed fungal endophthalmitis occurring after invasive ocular procedures were reported nationwide. We identified 47 cases in 9 states: 21 patients had been exposed to the intraocular dye Brilliant Blue G (BBG) during retinal surgery, and the other 26 had received an intravitreal injection containing triamcinolone acetonide. Both drugs were produced by Franck's Compounding Lab (Ocala, FL, USA). Fusarium incarnatum-equiseti species complex mold was identified in specimens from BBG-exposed case-patients and an unopened BBG vial. Bipolaris hawaiiensis mold was identified in specimens from triamcinolone-exposed case-patients. Exposure to either product was the only factor associated with case status. Of 40 case-patients for whom data were available, 39 (98%) lost vision. These concurrent outbreaks, associated with 1 compounding pharmacy, resulted in a product recall. Ensuring safety and integrity of compounded medications is critical for preventing further outbreaks associated with compounded products.


Subject(s)
Blindness/microbiology , Endophthalmitis/microbiology , Eye Infections, Fungal/microbiology , Ophthalmic Solutions/adverse effects , Rosaniline Dyes/adverse effects , Triamcinolone Acetonide/adverse effects , Aged , Aged, 80 and over , Blindness/epidemiology , Blindness/etiology , Blindness/surgery , Drug Recalls , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Endophthalmitis/surgery , Eye Infections, Fungal/epidemiology , Eye Infections, Fungal/etiology , Eye Infections, Fungal/surgery , Female , Fusarium/pathogenicity , Fusarium/physiology , Humans , Male , Middle Aged , Retina/microbiology , Retina/pathology , Retina/surgery , Saccharomycetales/pathogenicity , Saccharomycetales/physiology , United States/epidemiology , Vitreous Body/microbiology , Vitreous Body/pathology , Vitreous Body/surgery
4.
Diabetes Res Clin Pract ; 76(1): 44-50, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16959366

ABSTRACT

The predisposition to infection and chronic inflammation in diabetes may in part be related to the effects of hyperglycemia or other metabolic abnormality on polymorphonuclear leukocytes (PMN). We evaluated oxidative respiratory burst activity (superoxide production) in non-stimulated and stimulated PMN from 70 stable type 2 Hispanic diabetic patients, as compared to 70 healthy Hispanic individuals without diabetes. The influences of protein kinase C (PKC) inhibitors and certain antibiotics on superoxide production were examined. Both resting and stimulated (PMA, zymosan) PMN from diabetic individuals produced more superoxide than PMN from controls. Inhibitors of PKC, a possible mediator of the augmented respiratory burst activity, decreased superoxide production in all (resting and stimulated) diabetic and control PMN. Azithromycin, which is markedly concentrated by PMN, profoundly inhibited superoxide generation in all groups of diabetic and control cells. PMN from Hispanic diabetic patients produced greater quantities of superoxide than non-diabetic controls. This increased oxidative respiratory burst activity may predispose to infection and chronic inflammation in diabetes. PKC inhibitors and azithromycin inhibited this respiratory burst response. The possible role of PKC (especially PKC beta) as the mediator of this augmented respiratory burst response requires further evaluation, and may lead to therapeutic studies with appropriate inhibitors.


Subject(s)
Diabetes Mellitus, Type 2/blood , Neutrophils/physiology , Respiratory Burst , Anti-Bacterial Agents/pharmacology , Aza Compounds/pharmacology , Azithromycin/pharmacology , Case-Control Studies , Female , Fluoroquinolones , Humans , Male , Mexican Americans/statistics & numerical data , Moxifloxacin , Neutrophils/drug effects , Ofloxacin/pharmacology , Protein Kinase C/antagonists & inhibitors , Quinolines/pharmacology , Superoxides/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Zymosan/pharmacology
5.
Am J Gastroenterol ; 100(10): 2180-5, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16181366

ABSTRACT

OBJECTIVES: Our clinical experience suggested that hepatitis C virus (HCV) infection in this Texas-Mexico border area might have features, especially risk factors, that differ from some other areas of the United States. Therefore, we conducted a prospective analysis to investigate the epidemiology, risk factors, and certain other characteristics of HCV infection in the El Paso region. METHODS: During a 2-yr period, individuals with a positive HCV serology were considered as "patients" and those with a negative hepatitis serology panel were "controls." A questionnaire survey was conducted in person or by telephone with individuals (patients and controls) who agreed to participate in the interview process. RESULTS: We identified and interviewed 320 patients and 307 controls. All of the contacted patients and controls agreed to be interviewed. Many established and potential risk factors for HCV transmission were documented in the patients. Furthermore, multiple potential risk factors were often present in individual patients. However, on multivariate analysis only injection drug use, blood transfusion, and tattooing were found to be significant independent risk factors for HCV infection. In the great majority of patients, tattoos were applied by friends (including gang members), inmates in jail/prison, or self, rather than commercial parlors. CONCLUSIONS: Tattooing is an independent risk factor for HCV infection in this United States-Mexico border area. The role of nonsterile tattooing practices in HCV transmission merits additional examination in regard to precise risk settings, frequency, and mechanisms of infection.


Subject(s)
Hepatitis C/epidemiology , Hepatitis C/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Hispanic or Latino/statistics & numerical data , Humans , Male , Mexico , Middle Aged , Prospective Studies , Risk Factors , Sexual Behavior , Substance-Related Disorders/complications , Tattooing/adverse effects , Texas/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...